TTF1 and carcinoid tumor: As expected, immunohistochemical evaluation confirms the duality of the disease, with expression of specific markers both of thyroid (thyroglobulin, TTF1, calcitonin) and carcinoid (chromogranin A, synaptophysin, NSE and CD56).